explore -WSS

explore

author：entertainment 2025-09-30 18:54:47 - browse：444

BARCELONA, Spain — Some of the patients waiting in the oncology ward of a hospital here, with its green-tiled floor and white walls, had arrived for a newfangled remedy for blood cancers, what’s known as a CAR-T therapy.

The patients were not here for one of the brand-name medicines — a Kymriah or Yescarta — that have shown the power of these cell-based approaches and helped reap their makers hundreds of millions of dollars. Rather, they would be receiving a CAR-T brewed up right here at Hospital Clínic de Barcelona.

Under a special European policy, the CAR-T developed by the hospital’s experts had won regulatory approval in Spain and was reimbursed by the national health system like other authorized medications. The therapy provided another option for patients, all at a price of 89,000 euros ($97,000), roughly a third of the list prices of the CAR-T products from biopharma companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： An inside look at PIPEs, biotech's buzzy new financing tool

knowledge

entertainment

WSS

RSV vaccines may be linked to small increased risk of developing GBS

Astellas still sees hope in its gene therapy after four deaths

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

AstraZeneca loses challenge to Medicare drug price negotiation

ALS groups 'won't be played again' by the FDA, drug sponsors

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

focus

explore

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Biotech companies concerned about China biosecurity crackdown

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

An inside look at PIPEs, biotech's buzzy new financing tool

Affirmative action in medical school literally saved lives

Astellas still sees hope in its gene therapy after four deaths

Drug repurposing or repositioning? The language matters

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Malaria cases in Florida and Texas: Here’s what you need to know

David Sabatini, ex

hotspot

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Childhood cancer progress stalls for Black, Hispanic kids: Report

How to fix the rural physician shortage in the U.S.

AstraZeneca loses challenge to Medicare drug price negotiation

In search for therapies for solid tumors, companies turn to claudin

Kenai launches with $82 million for Parkinson’s stem cell therapy

knowledge

entertainment

hotspot

explore